Pre-eclampsia and fetal growth restriction arise from disorders of placental development and
have some shared mechanistic features. Initiation is often rooted in the maldevelopment of a …

Preeclampsia (PE) is a complex disorder that is characterized by hypertension and
proteinuria after the 20th week of pregnancy, and it causes most neonatal morbidity and …

Context There is a need to develop strategies for early prediction of patients who will
develop preeclampsia (PE) to establish preventive strategies to reduce the prevalence and …

Cardiovascular diseases are the number one cause of death worldwide and greatly impact
quality of life and medical costs. Enormous effort has been made in research to obtain new …

The aim of the study was to verify if quantification of placental specific C19MC microRNAs in
plasma exosomes would be able to differentiate during the early stages of gestation …

Pregnancy complications are a major cause of fetal and maternal morbidity and mortality in
humans. The majority of pregnancy complications initiate due to abnormal placental …

Objectives A nested case control study of a longitudinal cohort comparing pregnant women
enrolled at 10 to 13 gestational weeks was carried out to evaluate risk assessment for …

As critical mediators in biological processes, microRNAs (miRNAs) which are small and
endogenous noncoding RNAs have been associated with disease progression, cell …

Pre-eclampsia (PE) is a systemic maternal syndrome affecting 2-8% of pregnancies
worldwide and involving poor placental perfusion and impaired blood supply to the foetus. It …

In placental mammals, reproductive success, and maternal-fetal health substantially depend
on a well-being placenta, the interface between the fetus and the mother. Disorders in …